GPER1 and pachyonychia congenita: G-1, the selectively activating GPER-1, inhibited the growth of multiple PC cells in vitro and in vivo through Erk1/2 and c-jun/c-fos signaling pathways, which indicates that the G-1 may be a new option for PC through targeting GPER-1 [61].